Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PegBeron ± GM-CSF in HBeAg-positive chronic hepatitis B
CTR20150201Phase 2Completed
- Sponsor
- Tebao Biotech
- Start
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Tebao Biotech. Started Apr 2015; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20150201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150201.